1,046 results on '"Wei, Yu-Quan"'
Search Results
102. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine
103. Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model
104. Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery
105. IL‐18R‐dependent and independent pathways account for IL‐18‐enhanced antitumor ability of CAR‐T cells
106. Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice
107. Combination of vesicular stomatitis virus matrix protein gene therapy with low-dose cisplatin improves therapeutic efficacy against murine melonoma
108. Antitumor and anti-angiogenesis immunity induced by CR-SEREX-identified Xenopus RHAMM
109. CXC-chemokine-ligand-10 gene therapy efficiently inhibits the growth of cervical carcinoma on the basis of its anti-angiogenic and antiviral activity
110. Three-class classification models of logS and logP derived by using GA–CG–SVM approach
111. Endothelial cell-specific molecule 2 (ECSM2) modulates actin remodeling and epidermal growth factor receptor signaling
112. A Specific Pharmacophore Model of Aurora B Kinase Inhibitors and Virtual Screening Studies Based on it
113. Vascular endothelial cell antigen (VECA), a novel secreted protein: overexpression in Escherichia coli of the hexahistidine- tagged protein and production of polyclonal antibodies
114. Long-term stable expression of antisense cDNA of cyclin B1 profoundly inhibits the proliferation of tumor cells and suppresses tumorigenicity in implanted mice
115. Pharmacophore Modelling and Virtual Screening for Identification of New Aurora-A Kinase Inhibitors
116. Overexpression of JKTBP1 induces androgen-independent LNCaP cell proliferation through activation of epidermal growth factor-receptor (EGF-R)
117. Soluble expression of human DRR1 (down-regulated in renal cell carcinoma 1) in Escherichia coli and preparation of its polyclonal antibodies
118. Additional file 2: of RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma
119. Additional file 4: of Circular RNA F-circSR derived from SLC34A2-ROS1 fusion gene promotes cell migration in non-small cell lung cancer
120. Additional file 3: of Circular RNA F-circSR derived from SLC34A2-ROS1 fusion gene promotes cell migration in non-small cell lung cancer
121. Additional file 2: of Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis
122. Additional file 1: of Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis
123. Additional file 1: of RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma
124. Additional file 1: of Circular RNA F-circSR derived from SLC34A2-ROS1 fusion gene promotes cell migration in non-small cell lung cancer
125. Additional file 3: of RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma
126. Additional file 3: of Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis
127. Different attitudes of Chinese patients and their families toward truth telling of different stages of cancer†
128. Antitumour activity of cationic-liposome-conjugated adenovirus containing the CCL19 [chemokine (C-C motif) ligand 19] gene
129. Inhibition of proliferation and induction of apoptosis by abrogation of heat-shock protein (HSP) 70 expression in tumor cells
130. Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs
131. Capecitabine: A highly effective and safe first-line chemotherapy in Chinese patients with metastatic colorectal carcinoma (MCRC)
132. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2
133. The treatment effects and mechanism of highly agglutinative staphylococci, local therapy in patients with superficial metastatic tumor
134. AAV-mediated human PEDF inhibits tumor growth and metastasis in murine colorectal peritoneal carcinomatosis model
135. Additional file 2: of Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancer
136. Additional file 1: Table S1. of MicroRNA-302b negatively regulates IL-1β production in response to MSU crystals by targeting IRAK4 and EphA2
137. Additional file 1: of Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancer
138. Novel ROR1 inhibitor ARI-1 suppresses the development of non-small cell lung cancer
139. Preclinical Evaluation of Chimeric Antigen Receptor–Modified T Cells Specific to Epithelial Cell Adhesion Molecule for Treating Colorectal Cancer
140. MicroRNA Biogenesis is enhanced by Liposome- Encapsulated Pin1 Inhibitor in Hepatocellular Carcinoma
141. Identification of Glycine Receptor α3 as a Colchicine-Binding Protein
142. Clinical Evaluations of Toxicity and Efficacy of Nanoparticle-Mediated Gene Therapy
143. Anti-tumor activity of N-trimethyl chitosan-encapsulated camptothecin in a mouse melanoma model
144. Enhancement of cisplatin sensitivity in lewis lung carcinoma by liposome-mediated delivery of a survivin mutant
145. Anti-tumor effect of adenovirus-mediated gene transfer of pigment epithelium-derived factor on mouse B16-F10 melanoma
146. Chapter 7 - Recent Advances of Nanostructures in Antimicrobial Therapy
147. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34→Ala mutant
148. Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model
149. IL‐18R‐dependent and independent pathways account for IL‐18‐enhanced antitumor ability of CAR‐T cells.
150. Long Noncoding RNA AB074169 Inhibits Cell Proliferation via Modulation of KHSRP-Mediated CDKN1a Expression in Papillary Thyroid Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.